During the COVID-19 pandemic, scientific evidence has advanced in the assessment and establishment of treatments for COVID-19 patients, both inpatients and outpatients. However, these studies have focused on acute disease and there is a need to advance in the understanding of post-COVID-19 condition. Nowadays, this is one of the most relevant challenges, which has been approached by identifying, characterizing, and following patients with long-term manifestations, but also requires preparedness and equipping the health system for diagnosis and provision of clinical care, especially in resource-limited settings.

In this webinar experts and members of the Clinical Epidemiology Working Group of the COVID-19 Clinical Research Coalition will:

• Provide an overview of latest understanding of post-COVID-19 condition
• Give a brief overview of the most relevant ongoing or completed studies
• Discuss the preparedness and challenges of LMICs to attend patients with post-COVID-19 condition

Watch the recording

Agenda

Welcome and introduction – Prof. Juan Carlos Villar, Fundación Cardioinfantil, Colombia

A clinical case definition of post-COVID-19 condition by a Delphi consensus – Joan B Soriano, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid

Round table moderated by Dr Christine Sekaggya Wiltshire MBChB, MMed (Internal Medicine), PhD, FCP (ECSA)

Speakers:

• Dr Agustin Ciapponi, Cochrane Argentina, PI at Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina
• Ms Heather Stone, CURE ID, FDA, USA
• Dr Tanvir Ahmed, Sajida Foundation, Bangladesh

Q&A moderated by Prof. Richard Maude, Epidemiology Department, MORU, Thailand